Updated time: 2021-03-16 09:20:15
12A-1030310
US 10532097 B2、TW I604854、JP 63558412、AU 2015287696、EP 3166623、US 10912832 B2
We have developed a novel delivery strategy that involves creating a microenvironment with a specific target acting as a “Navigation Tip” that facilitates multiple administrations of therapeutics. The invention involves injecting a navigational mixture of antibodies with biomaterials at injured or operating sites, followed by systemically administrating a therapeutic that has been ligand- conjugated. The ligand-conjugated therapeutic will then be guided and circulated to the injection site. This system allows administration of therapeutics in a multiple times, sequentially or continuously way.
A novel reloadable delivery system allows ligand-conjugated therapeutics to be effectively delivered to any target tissues, repeatedly or sequentially, which minimizes the chance of inducing undesired effects, and improves therapeutic efficacy.
Ischemic heart diseases, diabetic complications such as ischemic leg and poor wound healing, and cancer.
Patrick CH Hsieh、Pei-Jung Wu、Steve Roffler、Bill Cheng
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

A reloadable delivery system for systemically administered therapeutics